Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a frailty score guide heart attack treatment for the elderly?

NCT ID NCT04488536

Knowledge-focused Sponsor: Linkoeping University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This study looks at how frailty, a measure of biological age, influences the care and outcomes of patients hospitalized with a heart attack. Researchers will analyze data from the Swedish SWEDEHEART registry, which includes information on thousands of patients. They will compare treatment patterns and outcomes, such as death and complications, across different levels of frailty. The goal is to see if frailty can help doctors decide which patients might benefit from more invasive procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Frailty assessment using the Clinical Frailty Scale
What this could lead to
If frailty proves to be a strong predictor of outcomes, doctors could use it to tailor heart attack treatments for older adults, potentially improving survival and reducing complications.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The results may be influenced by factors not fully accounted for, and the findings may not apply to all heart attack patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 10,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2020

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

SWEDEHEART is a national quality registry, which collects information on all patients hospitalized with MI or suspected MI. All 72 Swedish hospitals with acute coronary care contribute with data. From January 1st 2020 Clinical Frailty Scale, the 9-degree-version (CFS-9) is a mandatory variable in the registry. However, as a pilot project to ensure feasibility, five hospitals began to register frailty November 1st, 2017. Inclusion criteria: patients consecutively included in the SWEDEHEART registry from November 1, 2017. Exklusion criteria: none.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients consecutively included in the SWEDEHEART registry from November 1, 2017. Exclusion Criteria: * None.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty Myocardial infarction

Contacts and locations

Locations

  • Linkoeping University Hospital

    Linköping, Ostergoetland, Sweden

  • The Center for Medical Technology Assessment/IMH, Linkoeping University

    Linköping, Östergötland County, 58183, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.